Instituto Do Cancer Do Estado De São Paulo
Clinical trials sponsored by Instituto Do Cancer Do Estado De São Paulo, explained in plain language.
-
New hope for rare cancers: immunotherapy trial targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 17, 2026 00:51 UTC
-
Blood test could replace scans for HPV cancer patients
Disease control Recruiting nowThis study is testing a new, low-cost blood test that looks for tumor DNA (ctDNA) in people with HPV-related cervical or anal cancer after they finish radiation therapy. The goal is to see if this simple blood test can replace expensive imaging scans for monitoring and help docto…
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 07, 2026 18:42 UTC